Physician profile
Robert W Mosca
NPI 1508832718
$1,305.51
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $459 · 2020: $224 · 2021: $22.73 · 2022: $182 · 2023: $256 · 2024: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $417.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $402.12 | 2019-2024 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Novo Nordisk INC | $220.06 | 2019-2024 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $118.46 | 2019-2024 | Mounjaro, Zepbound, Jardiance |
| Pfizer INC. | $85.18 | 2020-2023 | |
| Glaxosmithkline, LLC. | $80.39 | 2019-2023 | Shingrix |
| Abbvie INC. | $60.29 | 2022-2024 | |
| Novartis Pharmaceuticals Corporation | $58.41 | 2022 | |
| Janssen Pharmaceuticals, INC | $58.05 | 2020-2023 | Xarelto |
| Astrazeneca Pharmaceuticals Lp | $41.04 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.47 | 2023 | |
| Avanir Pharmaceuticals, INC. | $35.30 | 2019 | |
| Amarin Pharma, INC. | $33.17 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.98 | 2023 | Xifaxan |
| Alexion Pharmaceuticals, INC. | $16.88 | 2023 | Strensiq |
| Daiichi Sankyo INC. | $15.62 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $14.19 | 2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $10.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mosca listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.